Aurinia Pharmaceuticals Inc (AUPH)
5.69
+0.09
(+1.61%)
USD |
NASDAQ |
Jul 26, 16:00
5.68
-0.01
(-0.18%)
After-Hours: 20:00
Aurinia Pharmaceuticals Price: 5.69 for July 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 25, 2024 | 5.55 | 5.71 | 5.47 | 5.60 | 1.496M |
| Jul 24, 2024 | 5.43 | 5.73 | 5.37 | 5.56 | 1.516M |
| Jul 23, 2024 | 5.39 | 5.57 | 5.38 | 5.45 | 1.528M |
| Jul 22, 2024 | 5.58 | 5.65 | 5.260 | 5.43 | 1.517M |
| Jul 19, 2024 | 5.60 | 5.755 | 5.51 | 5.56 | 2.053M |
| Jul 18, 2024 | 5.82 | 5.85 | 5.53 | 5.57 | 1.359M |
| Jul 17, 2024 | 5.67 | 5.84 | 5.66 | 5.84 | 1.064M |
| Jul 16, 2024 | 5.73 | 5.885 | 5.70 | 5.80 | 1.853M |
| Jul 15, 2024 | 5.61 | 5.675 | 5.54 | 5.67 | 1.601M |
| Jul 12, 2024 | 5.90 | 5.955 | 5.59 | 5.61 | 1.352M |
| Jul 11, 2024 | 5.57 | 5.900 | 5.55 | 5.86 | 2.446M |
| Jul 10, 2024 | 5.55 | 5.635 | 5.45 | 5.50 | 753343.0 |
| Jul 09, 2024 | 5.62 | 5.62 | 5.50 | 5.52 | 767338.0 |
| Jul 08, 2024 | 5.61 | 5.77 | 5.57 | 5.63 | 968815.0 |
| Jul 05, 2024 | 5.48 | 5.61 | 5.44 | 5.61 | 813623.0 |
| Jul 03, 2024 | 5.42 | 5.535 | 5.36 | 5.47 | 388374.0 |
| Jul 02, 2024 | 5.50 | 5.55 | 5.42 | 5.43 | 571187.0 |
| Jul 01, 2024 | 5.69 | 5.76 | 5.48 | 5.49 | 845475.0 |
| Jun 28, 2024 | 5.63 | 5.77 | 5.50 | 5.71 | 3.605M |
| Jun 27, 2024 | 5.54 | 5.62 | 5.46 | 5.62 | 585737.0 |
| Jun 26, 2024 | 5.54 | 5.56 | 5.46 | 5.51 | 878705.0 |
| Jun 25, 2024 | 5.66 | 5.698 | 5.57 | 5.57 | 683397.0 |
| Jun 24, 2024 | 5.52 | 5.695 | 5.52 | 5.66 | 780484.0 |
| Jun 21, 2024 | 5.49 | 5.57 | 5.47 | 5.53 | 1.100M |
| Jun 20, 2024 | 5.36 | 5.53 | 5.31 | 5.46 | 1.047M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.88
Minimum
Oct 14 2019
33.08
Maximum
Oct 29 2021
11.75
Average
11.22
Median
Price Benchmarks
| Acasti Pharma Inc | 2.71 |
| Edesa Biotech Inc | 5.42 |
| Lexaria Bioscience Corp | 3.37 |
| Xenon Pharmaceuticals Inc | 43.98 |
| ESSA Pharma Inc | 5.18 |
Price Related Metrics
| PS Ratio | 4.636 |
| Price to Book Value | 2.153 |
| Earnings Yield | -9.31% |
| Market Cap | 813.78M |